Search This Blog

Wednesday, August 7, 2019

Madrigal Pharmaceuticals EPS misses by $0.21

Madrigal Pharmaceuticals (NASDAQ:MDGL): Q2 GAAP EPS of -$1.28 misses by $0.21.
Cash and equivalents of $466.4M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)